ECEL1
Basic information
Region (hg38): 2:232479827-232487834
Links
Phenotypes
GenCC
Source:
- distal arthrogryposis type 5D (Definitive), mode of inheritance: AR
- distal arthrogryposis type 5D (Strong), mode of inheritance: AR
- distal arthrogryposis type 5D (Strong), mode of inheritance: AR
- distal arthrogryposis type 5D (Supportive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Arthrogryposis, distal, type 5D | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal | 23236030; 23261301; 25099528 |
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn_genetic_diseases (100 variants)
- not_provided (86 variants)
- Distal_arthrogryposis_type_5D (78 variants)
- ECEL1-related_disorder (23 variants)
- not_specified (14 variants)
- See_cases (4 variants)
- Distal_arthrogryposis (2 variants)
- Arthrogryposis_multiplex_congenita (2 variants)
- Arthrogryposis (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ECEL1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000004826.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 26 | 32 | ||||
missense | 15 | 118 | 16 | 156 | ||
nonsense | 10 | 17 | ||||
start loss | 1 | 1 | ||||
frameshift | 14 | |||||
splice donor/acceptor (+/-2bp) | 12 | |||||
Total | 33 | 31 | 120 | 42 | 6 |
Highest pathogenic variant AF is 0.00005709
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ECEL1 | protein_coding | protein_coding | ENST00000304546 | 17 | 8002 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.79e-13 | 0.984 | 125687 | 0 | 60 | 125747 | 0.000239 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.478 | 409 | 437 | 0.936 | 0.0000256 | 4917 |
Missense in Polyphen | 137 | 161.04 | 0.85072 | 1884 | ||
Synonymous | -0.324 | 197 | 191 | 1.03 | 0.0000116 | 1538 |
Loss of Function | 2.46 | 27 | 44.8 | 0.603 | 0.00000256 | 444 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00150 | 0.00150 |
Ashkenazi Jewish | 0.0000998 | 0.0000992 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000178 | 0.000176 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000229 | 0.000229 |
Other | 0.000491 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: May contribute to the degradation of peptide hormones and be involved in the inactivation of neuronal peptides.;
- Disease
- DISEASE: Arthrogryposis, distal, 5D (DA5D) [MIM:615065]: An autosomal recessive form of distal arthrogryposis, a disease characterized by congenital joint contractures that mainly involve two or more distal parts of the limbs, in the absence of a primary neurological or muscle disease. DA5D is characterized by severe camptodactyly of the hands, mild camptodactyly of the toes, clubfoot and/or a calcaneovalgus deformity, extension contractures of the knee, unilateral ptosis or ptosis that is more severe on one side, a round-shaped face, arched eyebrows, a bulbous upturned nose, and micrognathia. Patients do not have ophthalmoplegia. {ECO:0000269|PubMed:23236030, ECO:0000269|PubMed:23261301, ECO:0000269|PubMed:23808592, ECO:0000269|PubMed:23829171}. Note=The disease is caused by mutations affecting the gene represented in this entry. ECEL1 mutations have also been found in patients with arthrogryposis, significant ophthalmoplegia, and refractive errors (PubMed:23808592). {ECO:0000269|PubMed:23808592}.;
Recessive Scores
- pRec
- 0.205
Intolerance Scores
- loftool
- 0.207
- rvis_EVS
- 0
- rvis_percentile_EVS
- 54.07
Haploinsufficiency Scores
- pHI
- 0.130
- hipred
- Y
- hipred_score
- 0.782
- ghis
- 0.404
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.362
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ecel1
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- respiratory system process;proteolysis;neuropeptide signaling pathway
- Cellular component
- integral component of plasma membrane
- Molecular function
- metalloendopeptidase activity;metallopeptidase activity;metal ion binding